Press release
Jimmy’s Presents Ladies’ Couture to Benefit Alzheimer’s Association Long Island
On July 9, some of the most exquisite cocktail and evening wear and red-carpet ready-to-wear ladies’ fashions will be available for purchase at Jimmy’s, located at 167 Main Street in Westhampton Beach. Ten percent of the sales proceeds will benefit Alzheimer’s Association Long Island’s newly established satellite office at 33 Flying Point Road in Southampton.Those in attendance will get to meet internationally known fashion designer Lorena Sarbu. Originally from Romania, Ms. Sarbu moved to the United States, where she realized her childhood dream of becoming a designer. While studying business and design at the International Academy of Design & Technology in Chicago, she worked on designing her own creations that would eventually become her signature collection. She later continued her studies at the Fashion Institute of Design and Merchandising in Los Angeles. In 2009, Ms. Sarbu launched her elegant evening wear collection. A year later, she opened her own showroom in New York.
Ms. Sarbu infuses her glamorous and European-inspired personal style into each of her beautifully timeless creations. With an eye for exquisite detail, she combines sumptuous fabrics, unique textures and intricate embellishments to create distinctively stunning designs for the modern woman. She has already garnered a following in Hollywood, bringing style and glamour to the red carpet with her unique couture designs.
“We would like to thank Jimmy’s for hosting this wonderful event to benefit our new East End office,” said Mary Ann Malack-Ragona, Executive Director/Chief Executive Officer, Alzheimer’s Association Long Island. “With the addition of the Southampton office, those in the East End who suffer from Alzheimer’s disease will no longer have to travel great distances to receive services.”
According to Alzheimer’s Association Long Island, there are 5.4 million people who have Alzheimer’s disease and 60,000 of that number are living on Long Island. Alzheimer’s is the sixth leading cause of death in the U.S.
For more information about Alzheimer’s Association Long Island, please contact Mary Ann Malack-Ragona at (631) 820-8068 or visit www.alz.org/longisland.
For more than 20 years, the Alzheimer's Association has provided reliable information, created supportive programs and services for families, increased resources for dementia research, and influenced changes in public policy.
Hank Russell, Public Relations Director
The Public Relations and Marketing Group
156 North Ocean Avenue
Patchogue, NY 11772
(631) 207-1057
hrussell@theprmg.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Jimmy’s Presents Ladies’ Couture to Benefit Alzheimer’s Association Long Island here
News-ID: 181662 • Views: …
More Releases for Alzheimer
Dementia - Alzheimer Disease Market: A Comprehensive Analysis 2030
Dementia and Alzheimer's disease represent significant challenges within the global healthcare sector. These neurological disorders, characterized by progressive cognitive decline, have seen increasing prevalence due to aging populations worldwide. This growing burden has spurred interest in the Dementia - Alzheimer's disease market, encompassing diagnostic tools, treatments, caregiving solutions, and related healthcare services. This article provides an overview of the market, its scope, current trends, and factors driving its expansion.
Data Bridge…
Alzheimer Disease Treatment Market | Allergan, Amgen, Daiichi Sankyo, Eisai
The global alzheimer disease treatment market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the alzheimer disease treatment market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants.
From the perspective of market dynamics, this report explores the factors driving the growth…
United States Alzheimer Drugs Market Insights Deep Analysis 2023-2031
Cognate Life Sciences introduces a report on "United States Alzheimer Drugs Market 2023" with Market Insights Reports, Introduces systematic details in terms of market valuation, market size, revenue estimation, and geographical spectrum of the business vertical. The study also talks about crucial pockets of the industry such as products or services offered, downstream fields, end using customers, historic data figures regarding revenue and sales, market context and more. It conjointly…
Global Alzheimer Market, Global Alzheimer Industry, Covid-19 Impact Global Alzhe …
Alzheimer's is a progressive disease that leads to the death of brain cells, resulting in memory loss, behavioral issues, and disruption the thought processes. The Alzheimer disease is considered fatal. Age and heredity are the two main risk factors for developing Alzheimer's disease. Several other preventable risk factors have been associated to the development of this disease, including diet, environment, and overall general health. A combination of risk factors is…
US Alzheimer Drug Pipeline Analysis
In US, the Alzheimer's disease is the 6th leading cause of death overall and among those aged 65 and above, it is the 5th leading cause of death. While the deaths from major diseases, like heart disease have decreased, the death due to Alzheimer's have increased by more than 60% between 2000 and 2012. The total number of patients having Alzheimer’s disease was 5.4 million in 2012. Out of this,…
Global Alzheimer Market Report: 2015 Edition | Now Available at Researchmoz.us
Researchmoz added Most up-to-date research on "Global Alzheimer Market Report: 2015 Edition" to its huge collection of research reports.
Alzheimer’s disease is defined as an advanced neurological disorder that increasingly deprives patients of their memory and ability to carry out daily activities. As it grows in a human brain, individuals are likely to practice difficulties in linguistic, agility and insight along with negative changes in the character and performance such as…